{"id":4067,"date":"2025-05-20T10:30:30","date_gmt":"2025-05-20T10:30:30","guid":{"rendered":"https:\/\/scientificworld.org\/?p=4067"},"modified":"2025-05-20T10:30:37","modified_gmt":"2025-05-20T10:30:37","slug":"repurposed-diabetes-drug-shows-promise-in-reducing-knee-arthritis-pain","status":"publish","type":"post","link":"https:\/\/scientificworld.org\/?p=4067","title":{"rendered":"Repurposed Diabetes Drug Shows Promise in Reducing Knee Arthritis Pain"},"content":{"rendered":"\n<p>A common diabetes medication, metformin, has been found to alleviate knee pain in individuals with osteoarthritis (OA) and overweight or obesity, according to a study led by Monash University. Published in&nbsp;<a href=\"http:\/\/dx.doi.org\/10.1001\/jama.2025.3471\"><em>JAMA<\/em><\/a>, the research suggests that metformin could delay the need for knee replacements by offering a safe and affordable treatment option.<\/p>\n\n\n\n<p>&nbsp;The clinical trial involved 107 participants (73 women and 34 men) with symptomatic knee OA and a mean age of 60. None of the participants had diabetes. Over six months, those taking up to 2000 mg of metformin daily reported a 31.3-point reduction in pain on a 0-100 scale, compared to an 18.9-point reduction in the placebo group. This moderate pain relief highlights metformin\u2019s potential as a viable treatment.<\/p>\n\n\n\n<p>Current treatments for knee OA, such as exercise, weight loss, and medications like paracetamol or anti-inflammatory drugs, often provide limited benefits or pose safety concerns. No new OA drugs have been approved in Australia since the late 1990s. Metformin, already widely used for type 2 diabetes, offers a novel approach by targeting inflammation and metabolic pathways linked to OA pain. Lead researcher Professor Flavia Cicuttini emphasized the significance of the findings: \u201cMetformin is a low-cost, safe medication that could help patients manage knee pain and delay unnecessary knee replacements.\u201d She noted that dissatisfaction rates with knee replacements are high (20-30%), especially when performed for early-stage OA. Delaying surgery could improve patient outcomes and reduce healthcare costs.<\/p>\n\n\n\n<p>While the results are promising, the study\u2019s modest sample size calls for larger trials to confirm metformin\u2019s effectiveness. Researchers are now working to integrate metformin into knee OA management pathways, leveraging its safety profile and telehealth delivery potential to reach broader communities, including remote areas.<\/p>\n\n\n\n<p>Knee OA is a leading cause of pain and disability, with limited effective therapies. Metformin, known for its anti-inflammatory and metabolic benefits, may offer a new way to address this unmet need. Its repurposing for OA could mark a significant advancement in pain management.<\/p>\n\n\n\n<p>This study opens the door to a cost-effective, accessible treatment option for millions suffering from knee OA, potentially transforming how the condition is managed worldwide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A common diabetes medication, metformin, has been found to alleviate knee pain in individuals with osteoarthritis (OA) and overweight or obesity, according to a study led by Monash University. Published in&nbsp;JAMA, the research suggests that metformin could delay the need for knee replacements by offering a safe and affordable treatment option. &nbsp;The clinical trial involved [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1565],"tags":[320,1566],"class_list":["post-4067","post","type-post","status-publish","format-standard","hentry","category-health-medicine","tag-diabetes","tag-health-medicine"],"_links":{"self":[{"href":"https:\/\/scientificworld.org\/index.php?rest_route=\/wp\/v2\/posts\/4067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/scientificworld.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/scientificworld.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/scientificworld.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/scientificworld.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4067"}],"version-history":[{"count":2,"href":"https:\/\/scientificworld.org\/index.php?rest_route=\/wp\/v2\/posts\/4067\/revisions"}],"predecessor-version":[{"id":4069,"href":"https:\/\/scientificworld.org\/index.php?rest_route=\/wp\/v2\/posts\/4067\/revisions\/4069"}],"wp:attachment":[{"href":"https:\/\/scientificworld.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/scientificworld.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/scientificworld.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}